RENAL ANGIOMYOLIPOMA
Clinical trials for RENAL ANGIOMYOLIPOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL ANGIOMYOLIPOMA trials appear
Sign up with your email to follow new studies for RENAL ANGIOMYOLIPOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New medical device aims to starve tumors by cutting off blood supply
Disease control OngoingThis study is testing whether a new medical device called the GPX Embolic Device is safe and effective for blocking blood vessels. The device is designed to treat vascular tumors and other conditions by cutting off blood flow to specific areas. Researchers will follow 114 patient…
Matched conditions: RENAL ANGIOMYOLIPOMA
Phase: NA • Sponsor: Fluidx Medical Technology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Drug trial aims to shrink dangerous kidney tumors
Disease control OngoingThis study is checking the safety and effectiveness of the drug everolimus for Taiwanese adults with tuberous sclerosis complex who have non-cancerous kidney tumors called angiomyolipomas. It will follow a small group of eligible patients for about a year to see if the drug shrin…
Matched conditions: RENAL ANGIOMYOLIPOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC